| Oct 23 |
Viking Therapeutics GAAP EPS of -$0.22 beats by $0.03
|
| Oct 23 |
Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Oct 22 |
Viking Therapeutics Q3 2024 Earnings Preview
|
| Oct 22 |
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
|
| Oct 21 |
Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral
|
| Oct 21 |
Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings?
|
| Oct 18 |
State Street Corp's Strategic Reduction in Viking Therapeutics Holdings
|
| Oct 18 |
Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?
|
| Oct 17 |
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future
|
| Oct 16 |
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
|
